How To Check Goldline Pharmaceutical IPO Allotment Status Online?

(As on 14 May 2026, 5:00 PM IST) The allotment of Goldline Pharmaceutical IPO of ₹11.61 crores will take place on Friday, 15 May 2026. The subscription for the Goldline Pharmaceutical IPO closed on 14 May 2026. The IPO ran from 12 May 2026 to 14 May 2026 and was priced between ₹41 and ₹43 per share.

Goldline Pharmaceutical IPO subscribed total of 840.74 times. The public issue subscribed 881.15 times in the individual investors category, 180.22 times in QIB (Ex Anchor), and 1,662.04 times in the NII category.

How to check Goldline Pharmaceutical IPO Allotment Status on Registrar site

Step 1: Visit Bigshare Services Private Limited
Step 2: Select Goldline Pharmaceutical from the drop-down menu on the page
Step 3: Enter details required like PAN number, Application Number, or Demat Account Number.
Step 4: Click on the ‘Search’ Button
Step 5: Get your allotment status

How to check Goldline Pharmaceutical IPO Allotment Status on BSE website

Step 1: Go to the BSE website
Step 2: Click on ‘Status of Issue Application’ under ‘Investor Services’
Step 3: Click on ‘Application Status Check’
Step 4: Choose the ‘Issue Type’ and ‘Issue Name’
Step 5: Enter your PAN or Application Number
Step 6: Verify the box ‘I’m not a robot’
Step 7: Click on “Search to view allotment status”

How to check Goldline Pharmaceutical IPO Allotment Status on NSE website

Step 1: Open NSE INDIA website in your browser.
Step 2: In the top menu, click on Invest (or search for “Verify IPO Bids”)
Step 3: Under Resources & Tools, select “Verify IPO Bids / IPO Bid Verification”
Step 4: On the IPO Bid Verification page, select the Goldline Pharmaceutical from the dropdown
Step 5: Enter your Application Number or PAN in the required field
Step 6: Fill any other required fields (e.g., DP ID if requested)
Step 7: Complete the CAPTCHA / “I’m not a robot” check
Step 8: Click Submit (or Verify) to view your Goldline Pharmaceutical allotment status.

About Goldline Pharmaceutical

Goldline Pharmaceuticals operates under the well known brand name Goldline and has built its presence through the marketing of pharmaceutical products across multiple therapeutic divisions. The company functions through five separate segments.

• Goldline Pharma focuses on specialties such as Physicians, Orthopedics, ENT, Chest Physicians, General and Specialty Surgery, Gastroenterology, Neurology, and Urology.

• Goldline Cardinal reaches a wide clinical network. Physicians rely on it. So do Diabetologists, Endocrinologists, Cardiologists, and General Physicians.

• Goldline Ayushman is built for Pediatricians, Child Specialists, Neonatologists, along with General Practitioners.

• Goldline InLife, working alongside Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians.

• Goldline Wellness focuses entirely on cancer therapy products.

Its reach extends across several Indian states including Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar. Every product marketed by the company is sold and distributed under the Goldline brand name.

What happens if you get the Goldline Pharmaceutical IPO allotment?

If you are allotted the Goldline Pharmaceutical shares on 15 May 2026, the allotment day, the shares will be credited to your demat account on 18 May 2026. The money that was blocked for them will be debited from your linked bank account. Once you receive the shares, you can trade them or sell them after they are listed on 19 May 2026, on NSE or BSE.

What if you didn’t get the Goldline Pharmaceutical IPO allotment?

If you didn’t receive allotment of Goldline Pharmaceutical IPO:
• Refunds will be initiated on or about 18 May 2026.
• The amount will be credited to your bank account linked to UPI On the other hand, if allotted shares will reflect in your Demat by 18 May 2026.
• After the listing date, you can continue to track and invest in the stock directly through Kotak Neo

When is Goldline Pharmaceutical listing on the exchanges?

The shares of Goldline Pharmaceutical will be listed on BSE and NSE on or about 19 May 2026. You can track listing gains/losses on Kotak Neo.